Some push back on the notion that NIH spent hundreds of billions of dollars on basic research and therefore owns mRNA vaccine technology and has “march in” rights to dictate the use of pricing of this technology @RESachs@Dereklowe 1/
The fundamental contract underlying academic publication is that you publish your findings in return for recognition of priority, but once you have published others are free to use and build on your work. It’s practice established in the time of Newton and honored ever since
2/
No question mRNA vaccines draw on much basic molecular biology and would not have be possible without the work of Avery, MacLeod, Hershey, Chase, Nirenberg, Jacob & Monod, Sanger, Mullis, and many others. These scientists have received many well justified accolades and honors
3/
The same also applies to the discovery and characterization of coronaviruses. But a key point, biology itself cannot be patented and the patents on basic molecular biology have long ago expired 4/ en.wikipedia.org/wiki/Associati….
Who funded mRNA vaccine development? Moderna received multiple private funding rounds prior to Operation Warp Speed:
2012 $40M
2013 $24.6M DARPA
2014 $135M
2015 $ 446M
2016 $20M Gates Foundation
2016 $454M
2016 $8M BARDA
2018 $500M
2018 $125M 5/ craft.co/moderna-therap…
Similarly, BioNTech received multiple rounds of private funding prior to COVID-19:
2017 E$ 270M
2019 E$ 80M
2109 E$ 325M
2019 E$ 55M Gates Foundation
2019 E$ 50M 6/ crunchbase.com/organization/b…
Prior to COVID total government funding $33M, Gates Foundation $75M, private investors $2.4B. The grants and contracts through which Moderna and BioNTech received government funding include explicit commitments and deliverables which we assume have been and are being honored
7/
DARPA deserves real credit for a substantial early investment, but the idea that government funding of mRNA therapeutics development has been so substantial that government should have a controlling interest in the technology is laughable
/8
The NIH has supported work on mRNA vaccines, but only about $34M in funding over the past 5 years. This is a tiny fraction of the $2.4B private investors put into Moderna, BioNTech and more funding to numerous other companies 9/ projectreporter.nih.gov/reporter_searc…
Are mRNA vaccines obvious? Moderna as 327 US patents on RNA therapeutics (patents.google.com/?assignee=mode…) and BioNTech has 61 (patents.google.com/?assignee=Bion…). Evidently the USPTO feels that these companies have made numerous discoveries that are novel, nonobvious and useful
10/
So let’s agree that the founders of molecular biology long ago received their accolades, applaud DARPA for foresight, recognize the private investors who really funded the development mRNA vaccine technology, and stop with the march in rights polemics
11/fin
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Despite the catchy headline, the mandate of the CDC is far broader than pandemics, and the problems at the CDC precede COVID-19. But yes, the response to the COVID-19 pandemic was deeply flawed and systemic 1/ nytimes.com/2020/06/03/us/…
Vaccination is a key public health responsibility, and the US does well on influenza vaccination of the elderly, but we are middle of the pack on childhood vaccination rates 2/ data.oecd.org/healthcare/inf…
The Obesity Epidemic has been a disaster. Remember back when Surgeon General Luther Terry took on big tobacco and won? Big food not so much 3/ thelancet.com/journals/lanpu…
Let’s talk about Fall Semester. Colleges and universities have to make some big decisions soon 1/
And it won’t affect just students. For example, the University of Michigan #GoBlue has 46,000 students but it also has 25,000 faculty and staff. While students may be mostly young, many faculty and staff are in vulnerable age groups 2/ cupahr.org/wp-content/upl…
There’s also real meaning to “university community”, schools are densely linked social networks with multiple paths linking students, e.g. classes. Eliminating large classes can reduce but not eliminate the potential for epidemic spread 3/ osf.io/6kuet/
Epidemiologists and economists say we need millions if not tens of millions of tests/day to convince people it's safe to re-open the economy, e.g. this Harvard study estimates we'll need 20 millions tests per day ethics.harvard.edu/Covid-Roadmap
1/
Nobel Laurette Paul Romer’s @paulmromer simulations say we need to test everyone in the US every two weeks, or about 25 million tests per day paulromer.net/covid-sim-part…
2/
The most sensitive and specific tests for COVID-19 use quantitative RTPCR. We have about 1,000 instruments each able to run about 1,000 RTPCR tests per day for a national capacity of about a million tests per day.
3/
The explosive growth seen in early outbreaks within community may be a result of highly exposed individuals rapidly spreading to their many connections. As we re-open we may see slower spread because many of the highly connected people are now immune 1/
But it’s important note that this phenomenon only applies after the virus has been spreading in the community for a while. As the people of Albany Georgia learned, it only takes one individual in the wrong setting to trigger a large outbreak 2/
Also we talk to much about testing as binary “+” or “-“, but positive at Ct 16 on an RTPCR is a millions times more virus than positive at Ct 36. Bad things happened when a highly contagious person shedding lots of virus gets into a setting where many people can be exposed 3/
Let’s get real on test/trace/isolate. We have ~30k new testing confirmed cases per day. That mean we actually have ~300k new cases per day. Contact tracking is a lot of work, and BLS says we only have about 56 community health workers 1/ bls.gov/oes/2018/may/o…
First let’s define the problem. Figure shows the amount of virus being shed from the day of onset of symptoms. For both mild and severe cases, it’s already decreasing when symptoms start 2/ nature.com/articles/s4159…
Presymptomatic viral shedding means you need to catch infected people quickly before they infect others. And SARSCOV2 is a highly contagious virus, you need to trace and isolate most of the infected contacts or it keeps spreading
3/
Let’s talk testing, specifically the coronavirus test we really need and essentially no one is talking about. What we need is a fast, low cost field test for highly contagious people, and tests like this exist, in fact they’ve been around quite a while
1/
Full disclosure. I am an exec in a biotech company, and my company is developing tests for SARS-CoV-2. I try to keep my posts objective, but obviously I believe that this is an important issue and that the solutions we are pursuing have merit
2/
People are contagious for COVID-19 before they develop symptoms, and the number of virus shed varies dramatically from person to person and for any given person from day to day. This makes testing a challenge 3/ nature.com/articles/s4159…